Cargando…
Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
OBJECTIVE: Preterm infants are at a high risk of developing BPD. Although progression in neonatal care has improved, BPD still causes significant morbidity and mortality, which can be attributed to the limited therapeutic choices for BPD. This review discusses the potential of MSC in treating BPD as...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527154/ https://www.ncbi.nlm.nih.gov/pubmed/36055758 http://dx.doi.org/10.1111/crj.13540 |